- 首页>
- 上海品茶会所ZJV>
- s, especially those with taste changes or dietary limits, to stick with the treatment. In a nutshell, BDENZA ORAL SOLUTION is a simpler, more patient-friendly way to tackle prostate cancer. It can help improving the patient compliance to a great extent,” Dr. Aravind Badiger Director, Technical Formulation said in a statement.
BDENZA ORAL SOLUTION represents a significant advancement in prostate cancer therapy, offering relief and hope to millions of patients worldwide.
“BDENZA represents a paradigm shift in prostate cancer therapy. Its introduction aligns with our relentless pursuit to provide accessible and patient-centric healthcare solutions. This first-of-its-kind oral solution that addresses the challenges faced by many patients, offering convenience, reduced side effects, and a palatable sugar-free taste and affordability,” Raheel Shah, BDR Group Director (Business Development) said in a statement.
s, especially those with taste changes or dietary limits, to stick with the treatment. In a nutshell, BDENZA ORAL SOLUTION is a simpler, more patient-friendly way to tackle prostate cancer. It can help improving the patient compliance to a great extent,” Dr. Aravind Badiger Director, Technical Formulation said in a statement.
BDENZA ORAL SOLUTION represents a significant advancement in prostate cancer therapy, offering relief and hope to millions of patients worldwide.
“BDENZA represents a paradigm shift in prostate cancer therapy. Its introduction aligns with our relentless pursuit to provide accessible and patient-centric healthcare solutions. This first-of-its-kind oral solution that addresses the challenges faced by many patients, offering convenience, reduced side effects, and a palatable sugar-free taste and affordability,” Raheel Shah, BDR Group Director (Business Development) said in a statement.
时间:2024-06-17 04:44:47 阅读(143)
猜你喜欢
- Will Nifty hold 21,500 levels or dip further- See GIFT Nifty, FII data, F&O ban, crude, more before market opens
- Nifty support at 15800 today, be cautious in Bank Nifty; use Call Ladder in Nifty for gains on next F&O expiry
- Nifty to head towards 19400, Bank Nifty support at 41800; buy Reliance, TCS, SBI stocks for gains
- Zila Parishad Nagpur launches an entrepreneurship programme in district schools in collaboration with ULF and GAME
- Nifty needs to hold 17600 to scale 18000, expect north-bound journey; Buy Tata Steel, Siemens shares
- Will Nifty extend losses for 8th session or will Q3 GDP bring cheer- 8 things to know before market opens
- Gold Price Today, 22 June 2022- Gold gets cheaper on higher dollar, recession fears; support at Rs 50300
- Will Nifty extend losses for 8th session or will Q3 GDP bring cheer- 8 things to know before market opens
- YearEnder 2023- From P C Chandra Jewellers to Nike; a sneak peek into print ads rolled out this year